Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Astrocytoma 8Glioblastoma 5Neuroectodermal Tumors, Primitive 3Recurrence 2Oligodendroglioma 2Neurocytoma 2Lymphoma, Non-Hodgkin 2Glioma 2Brain Neoplasms 2Rhabdoid Tumor 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Multiple Myeloma 1Mesothelioma, Malignant 1Meningioma 1Melanoma 1Lung Neoplasms 1Gliosarcoma 1Ganglioglioma 1Esophageal Neoplasms 1Ependymoma 1Craniopharyngioma 1Carcinoma, Non-Small-Cell Lung 1Adrenocortical Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Dexamethasone 277Lenalidomide 155Bortezomib 152Cyclophosphamide 115Melphalan 107Calcium Dobesilate 107fludarabine phosphate 70carfilzomib 61pomalidomide 55Peripheral Blood Stem Cell Transplantation 53Whole-Body Irradiation 52Mycophenolic Acid 52Granulocyte Colony-Stimulating Factor 52Filgrastim 52daratumumab 46fludarabine 43Tacrolimus 41ixazomib 40Busulfan 40Thalidomide 36Cyclosporine 32dexamethasone acetate 26Stem Cell Transplantation 26Antilymphocyte Serum 25dexamethasone 21-phosphate 22plerixafor 20auricularum 20belantamab mafodotin 19Prednisone 19Etoposide 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Multiple Myeloma × antineoplaston AS 2-1 × Clear all
NCT00003511 2021-06-09

Antineoplaston Therapy in Treating Patients With Multiple Myeloma

Burzynski Research Institute

Phase 2 Terminated
5 enrolled 5 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡